Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-May-21 4:19 PM View:  | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 3,671,960 | -- | -- | 47% 7.81M to 11.48M | |
| 06-May-21 4:19 PM View: | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 150,799 | $16.00 | $2,412,780.00 | 1% 11.48M to 11.63M | |
| 20-Oct-20 4:18 PM View: | Turmeric Acquisition Corp. (TMPM) | 20-Oct-20 | Acquisition (other) Duplicate | 415,500 | $10.00 | $4,155,000.00 | 100% 0 to 415.5K | |
| 08-Oct-20 6:27 PM View: | Oncorus, Inc. (ONCR) | 06-Oct-20 | Conversion | 2,225,800 | -- | -- | 54% 4.1M to 6.32M | |
| 08-Oct-20 6:27 PM View: | Oncorus, Inc. (ONCR) | 06-Oct-20 | Purchase | 151,225 | $15.00 | $2,268,380.00 | 2% 6.32M to 6.48M | |
| 14-Feb-19 5:19 PM View: | Harpoon Therapeutics, Inc. (HARP) | 12-Feb-19 | Conversion Duplicate | 3,521,770 | -- | -- | 20% 17.99M to 21.51M | |
| 14-Feb-19 5:19 PM View: | Harpoon Therapeutics, Inc. (HARP) | 12-Feb-19 | Payment of Exercise | 1,524 | $14.00 | $21,336.00 | (< 1%) 22.19M to 22.19M | |
| 14-Feb-19 5:19 PM View: | Harpoon Therapeutics, Inc. (HARP) | 12-Feb-19 | Purchase Duplicate | 250,000 | $14.00 | $3,500,000.00 | 1% 21.51M to 21.76M | |
| 14-Feb-19 5:19 PM View: | Harpoon Therapeutics, Inc. (HARP) | 12-Feb-19 | Exercise (in-the money or at-the-money) Duplicate | 432,119 | $0.05 | $21,260.30 | 2% 21.76M to 22.19M | |
| 29-Sep-16 6:05 PM View: | Radius Health, Inc. (RDUS) | 27-Sep-16 | Disposition (other) Duplicate | 1,943,750 | -- | -- | (33%) 5.83M to 3.89M | |
| 08-Mar-16 6:37 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 08-Mar-16 | Conversion | 2,168,690 | -- | -- | 100% 0 to 2.17M | |
| 10-Jun-14 6:34 PM View: | Radius Health, Inc. (RDUS) | 06-Jun-14 | Conversion | 4,743,000 | -- | -- | 33% 14.39M to 19.13M | |
| 10-Jun-14 6:34 PM View: | Radius Health, Inc. (RDUS) | 06-Jun-14 | Acquisition (other) | 1,088,250 | -- | -- | 6% 19.13M to 20.22M | |
| 11-Feb-14 3:54 PM View: | Epizyme, Inc. (EPZM) | 10-Feb-14 | Market Sale Duplicate | 466,666 | $29.25 | $13,650,000.00 | (16%) 2.88M to 2.41M | 64% |
| 09-Jan-14 2:26 PM View: | EnteroMedics, Inc. (RSLS) | 08-Jan-14 | Market Sale | 284,531 | $2.50 | $711,328.00 | (6%) 4.38M to 4.1M | 100% |
| 09-Jan-14 2:26 PM View: | EnteroMedics, Inc. (RSLS) | 07-Jan-14 | Market Sale | 190,334 | $2.50 | $475,835.00 | (4%) 4.57M to 4.38M | 100% |
| 09-Jan-14 2:26 PM View: | EnteroMedics, Inc. (RSLS) | 06-Jan-14 | Market Sale | 81,720 | $2.50 | $204,300.00 | (2%) 4.66M to 4.57M | 100% |
| 01-Aug-13 2:19 PM View: | Histogen Inc. (HSTO) | 30-Jul-13 | Conversion Duplicate | 1,010,100 | -- | -- | 50% 2.04M to 3.05M | |
| 01-Aug-13 2:19 PM View: | Histogen Inc. (HSTO) | 30-Jul-13 | Acquisition (other) Duplicate | 16,716 | $11.00 | $183,876.00 | < 1% 3.05M to 3.06M | |
| 01-Aug-13 2:19 PM View: | Histogen Inc. (HSTO) | 30-Jul-13 | Purchase Duplicate | 165,265 | $11.00 | $1,817,920.00 | 5% 3.06M to 3.23M | |
| 13-Jun-13 3:52 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Jun-13 | Market Sale (Planned) | 20,311 | $30.07 | $610,843.00 | (2%) 844.57K to 824.25K | (97%) |
| 13-Jun-13 3:52 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-13 | Market Sale (Planned) | 2,435 | $30.00 | $73,050.00 | (< 1%) 847.0K to 844.57K | (98%) |
| 06-Jun-13 4:45 PM View: | Epizyme, Inc. (EPZM) | 05-Jun-13 | Conversion | 2,702,150 | -- | -- | 101% 2.67M to 5.37M | |
| 04-Jun-13 12:41 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Jun-13 | Market Sale (Planned) | 82,072 | $30.00 | $2,462,160.00 | (9%) 929.07K to 847.0K | (98%) |
| 03-Jun-13 4:04 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 31-May-13 | Market Sale (Planned) | 9,935 | $30.00 | $298,050.00 | (< 1%) 1.86M to 1.85M | (98%) |
| 03-Jun-13 4:04 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 30-May-13 | Market Sale (Planned) | 44,582 | $30.00 | $1,337,460.00 | (2%) 1.9M to 1.86M | (98%) |
| 30-May-13 2:47 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 29-May-13 | Market Sale (Planned) | 20,411 | $30.00 | $612,330.00 | (< 1%) 4.03M to 4.01M | (98%) |
| 30-May-13 2:47 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 28-May-13 | Market Sale (Planned) | 195,117 | $30.95 | $6,039,520.00 | (5%) 4.23M to 4.03M | (91%) |
| 23-May-13 5:48 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 22-May-13 | Market Sale (Planned) | 7,340 | $30.00 | $220,200.00 | (< 1%) 1.21M to 1.2M | (98%) |
| 21-May-13 1:44 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 20-May-13 | Market Sale (Planned) | 13,550 | $30.00 | $406,500.00 | (1%) 1.22M to 1.21M | (98%) |
| 29-Apr-13 4:50 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 24-Apr-13 | Market Sale (Planned) | 6,303 | $30.04 | $189,342.00 | (< 1%) 2.36M to 2.36M | (97%) |
| 29-Apr-13 4:50 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 23-Apr-13 | Market Sale (Planned) | 108,115 | $30.00 | $3,243,450.00 | (4%) 2.47M to 2.36M | (98%) |
| 18-Apr-13 5:10 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Apr-13 | Market Sale (Planned) | 2,575 | $30.00 | $77,250.00 | (< 1%) 2.58M to 2.58M | (98%) |
| 18-Apr-13 5:10 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Apr-13 | Market Sale (Planned) Duplicate | 10,000 | $30.00 | $300,000.00 | (< 1%) 2.59M to 2.58M | (98%) |
| 08-May-13 12:55 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Apr-13 | Market Sale | 3,416 | $29.30 | $100,089.00 | (< 1%) 2.66M to 2.65M | (102%) |
| 08-May-13 12:55 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Apr-13 | Exercise (in-the money or at-the-money) | 37,192 | $2.69 | $100,046.00 | 1% 2.62M to 2.66M | |
| 19-Mar-13 3:25 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 18-Mar-13 | Market Sale | 500,000 | $28.44 | $14,220,000.00 | (18%) 2.79M to 2.29M | (108%) |
| 13-Mar-13 12:29 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 11-Mar-13 | Market Sale Duplicate | 500,000 | $27.86 | $13,930,000.00 | (15%) 3.29M to 2.79M | (113%) |
| 07-Feb-13 2:33 PM View: | KaloBios Pharmaceuticals, I... (HGEN) | 05-Feb-13 | Conversion Duplicate | 2,632,930 | -- | -- | 62% 4.27M to 6.9M | |
| 10-Jul-12 2:10 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 09-Jul-12 | Market Sale | 1,624,570 | $0.31 | $498,744.00 | (28%) 5.8M to 4.18M | (30%) |
| 10-Jul-12 2:10 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Jul-12 | Market Sale | 671,217 | $0.29 | $195,324.00 | (10%) 6.47M to 5.8M | 33% |
| 05-Jul-12 11:59 AM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 03-Jul-12 | Market Sale | 98,210 | $0.29 | $28,480.90 | (1%) 7.34M to 7.24M | 33% |
| 05-Jul-12 11:59 AM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jul-12 | Market Sale | 80,348 | $0.29 | $23,300.90 | (1%) 7.42M to 7.34M | 32% |
| 02-Jul-12 2:13 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 28-Jun-12 | Market Sale Duplicate | 19,500 | $0.29 | $5,655.00 | (< 1%) 3.77M to 3.75M | 34% |
| 21-Jun-12 4:46 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 19-Jun-12 | Market Sale | 12,000 | $0.29 | $3,480.00 | (< 1%) 3.77M to 3.76M | 35% |
| 19-Jun-12 2:31 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 15-Jun-12 | Market Sale Duplicate | 1,450 | $0.29 | $420.50 | (< 1%) 3.78M to 3.78M | 31% |
| 07-Jun-12 3:44 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Jun-12 | Market Sale | 8,400 | $0.29 | $2,436.00 | (< 1%) 7.58M to 7.57M | 31% |
| 07-Jun-12 3:44 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 05-Jun-12 | Market Sale | 29,555 | $0.29 | $8,570.95 | (< 1%) 7.61M to 7.58M | 31% |
| 04-Jun-12 4:54 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-May-12 | Market Sale Duplicate | 29,850 | $0.30 | $8,955.00 | (< 1%) 24.08M to 24.05M | 33% |
| 04-Jun-12 4:54 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-May-12 | Market Sale Duplicate | 51,007 | $0.30 | $15,302.10 | (< 1%) 24.13M to 24.08M | 33% |